Shopping Cart
- Remove All
 
Your shopping cart is currently empty
EGFR/HER2-IN-13 (Compd 38) serves as an inhibitor targeting mutant EGFR/HER2s that show resistance to existing drugs. It is primarily utilized in cancer research.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | $1,670 | 8-10 weeks | |
| 50 mg | $2,180 | 8-10 weeks | |
| 100 mg | $2,800 | 8-10 weeks | 
| Description | EGFR/HER2-IN-13 (Compd 38) serves as an inhibitor targeting mutant EGFR/HER2s that show resistance to existing drugs. It is primarily utilized in cancer research.  | 
| In vitro | EGFR/HER2-IN-13 exhibits an IC50 of less than 100 nM in Ba/F3 cells transfected with mutated EGFR variants insASV, insSVD, and insGSP [1].  | 
| Molecular Weight | 520.63 | 
| Formula | C27H36N8O3 | 
| Cas No. | 3034701-46-4 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.